Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Applied Therapeutics Inc’s stock clocked out at $0.65, up 5.25% from its previous closing price of $0.62. In other words, the price has increased by $5.25 from its previous closing price. On the day, 8.51 million shares were traded. APLT stock price reached its highest trading level at $0.6908 during the session, while it also had its lowest trading level at $0.6061.
Ratios:
To gain a deeper understanding of APLT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Funtleyder Leslie D. sold 13,530 shares for $5.83 per share. The transaction valued at 78,880 led to the insider holds 277,911 shares of the business.
Perfetti Riccardo sold 22,681 shares of APLT for $132,230 on Aug 22 ’24. The Chief Medical Officer now owns 986,853 shares after completing the transaction at $5.83 per share. On Aug 13 ’24, another insider, Shendelman Shoshana, who serves as the President and CEO of the company, sold 357,423 shares for $6.18 each. As a result, the insider received 2,208,874 and left with 4,810,430 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 75980464 and an Enterprise Value of -20915222. Its current Enterprise Value per Revenue stands at 98.657 whereas that against EBITDA is 0.227.
Stock Price History:
The Beta on a monthly basis for APLT is 1.92, which has changed by -0.76254547 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -83.18%, while the 200-Day Moving Average is calculated to be -87.82%.
Shares Statistics:
It appears that APLT traded 6.44M shares on average per day over the past three months and 8436590 shares per day over the past ten days. A total of 116.36M shares are outstanding, with a floating share count of 86.61M. Insiders hold about 25.56% of the company’s shares, while institutions hold 88.10% stake in the company. Shares short for APLT as of 1735603200 were 19155154 with a Short Ratio of 2.98, compared to 1732838400 on 14175807. Therefore, it implies a Short% of Shares Outstanding of 19155154 and a Short% of Float of 18.38.
